North America Large And Small-scale Bioprocessing Market Size, Share & Industry Trends Analysis Report By Scale, By Use Type, By Mode (In-house, and Outsourced), By Application, By Workflow, By Product, By Country and Growth Forecast, 2023 - 2030
Description
North America Large And Small-scale Bioprocessing Market Size, Share & Industry Trends Analysis Report By Scale, By Use Type, By Mode (In-house, and Outsourced), By Application, By Workflow, By Product, By Country and Growth Forecast, 2023 - 2030
The North America Large And Small-scale Bioprocessing Market would witness market growth of 13.4% CAGR during the forecast period (2023-2030).
Large-scale bioprocessing continues to be driven primarily by the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. This trend is likely to persist as the demand for biologics remains high. The adoption of single-use bioprocessing technologies is increasing in large-scale bioprocessing. Single-use systems offer flexibility, reduce the risk of cross-contamination, and lower operational costs compared to traditional stainless-steel systems. There is a growing interest in continuous bioprocessing as it provides improved process control, reduced production costs, and faster time-to-market.
Miniaturization of bioprocessing equipment and the use of microfluidic devices are gaining traction in small-scale bioprocessing. These technologies enable rapid prototyping and experimentation. Small-scale bioprocessing is essential for developing and manufacturing cell and gene therapies, which have grown tremendously in recent years. Small-scale bioprocessing is particularly suited for customized and personalized medicine approaches, allowing for tailored treatments based on individual patient needs. Small-scale bioprocessing is widely used in academic and research labs for bioprocess development and optimization, and this trend is expected to continue.
North America is a thriving hub for the market, with a diverse and dynamic ecosystem encompassing pharmaceutical giants, biotech startups, academic research, and contract service providers. This diversity and innovation continue to drive advancements in bioprocessing technologies and contribute to the growth of the biopharmaceutical industry in the region. Due to these aspects, the market will grow in upcoming years.
The US market dominated the North America Large And Small-scale Bioprocessing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $39,322.4 million by 2030. The Canada market is registering a CAGR of 16% during (2023 - 2030). Additionally, The Mexico market would showcase a CAGR of 15% during (2023 - 2030).
Based on Scale, the market is segmented into Industrial Scale, and Small Scale. Based on Use Type, the market is segmented into Multi Use, and Single Use. Based on Mode, the market is segmented into In-house, and Outsourced. Based on Application, the market is segmented into Biopharmaceuticals, Speciality Industrial Chemicals, and Environmental Aids. Based on Workflow, the market is segmented into Industrial Downstream Processing, Fermentation, and Upstream Processing. Based on Product, the market is segmented into Bioreactors/Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags & Containers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., GE healthcare, Corning Incorporated, Sartorius AG, Lonza Group AG (Capsugel), Meissner Filtration Products, Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd. and Eppendorf SE.
Scope of the Study
Market Segments covered in the Report:
By Scale
- Industrial Scale
- Small Scale
- Multi Use
- Single Use
- In-house
- Outsourced
- Biopharmaceuticals
- Speciality Industrial Chemicals
- Environmental Aids
- Downstream Processing
- Fermentation
- Upstream Processing
- Bioreactors/Fermenters
- Cell Culture Products
- Filtration Assemblies
- Bioreactors Accessories
- Bags & Containers
- Others
- US
- Canada
- Mexico
- Rest of North America
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- GE healthcare
- Corning Incorporated
- Sartorius AG
- Lonza Group AG (Capsugel)
- Meissner Filtration Products, Inc.
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- Eppendorf SE
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
174 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Large And Small-scale Bioprocessing Market, by Scale
- 1.4.2 North America Large And Small-scale Bioprocessing Market, by Use Type
- 1.4.3 North America Large And Small-scale Bioprocessing Market, by Mode
- 1.4.4 North America Large And Small-scale Bioprocessing Market, by Application
- 1.4.5 North America Large And Small-scale Bioprocessing Market, by Workflow
- 1.4.6 North America Large And Small-scale Bioprocessing Market, by Product
- 1.4.7 North America Large And Small-scale Bioprocessing Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market At a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Geographical Expansion
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.3.2 Key Strategic Move: (Geographical Expansions : 2019, Jan – 2023, Jul) Leading Players
- 4.4 Porter’s Five Forces Analysis
- Chapter 5. North America Large And Small-scale Bioprocessing Market by Scale
- 5.1 North America Industrial Scale Market by Region
- 5.2 North America Small Scale Market by Region
- Chapter 6. North America Large And Small-scale Bioprocessing Market by Use Type
- 6.1 North America Multi Use Market by Region
- 6.2 North America Single Use Market by Region
- Chapter 7. North America Large And Small-scale Bioprocessing Market by Mode
- 7.1 North America In-house Market by Country
- 7.2 North America Outsourced Market by Country
- Chapter 8. North America Large And Small-scale Bioprocessing Market by Application
- 8.1 North America Biopharmaceuticals Market by Country
- 8.2 North America Speciality Industrial Chemicals Market by Country
- 8.3 North America Environmental Aids Market by Country
- Chapter 9. North America Large And Small-scale Bioprocessing Market by Workflow
- 9.1 North America Downstream Processing Market by Country
- 9.2 North America Fermentation Market by Country
- 9.3 North America Upstream Processing Market by Country
- Chapter 10. North America Large And Small-scale Bioprocessing Market by Product
- 10.1 North America Bioreactors/Fermenters Market by Country
- 10.2 North America Cell Culture Products Market by Country
- 10.3 North America Filtration Assemblies Market by Country
- 10.4 North America Bioreactors Accessories Market by Country
- 10.5 North America Bags & Containers Market by Country
- 10.6 North America Others Market by Country
- Chapter 11. North America Large And Small-scale Bioprocessing Market by Country
- 11.1 US Large And Small-scale Bioprocessing Market
- 11.1.1 US Large And Small-scale Bioprocessing Market by Scale
- 11.1.2 US Large And Small-scale Bioprocessing Market by Use Type
- 11.1.3 US Large And Small-scale Bioprocessing Market by Mode
- 11.1.4 US Large And Small-scale Bioprocessing Market by Application
- 11.1.5 US Large And Small-scale Bioprocessing Market by Workflow
- 11.1.6 US Large And Small-scale Bioprocessing Market by Product
- 11.2 Canada Large And Small-scale Bioprocessing Market
- 11.2.1 Canada Large And Small-scale Bioprocessing Market by Scale
- 11.2.2 Canada Large And Small-scale Bioprocessing Market by Use Type
- 11.2.3 Canada Large And Small-scale Bioprocessing Market by Mode
- 11.2.4 Canada Large And Small-scale Bioprocessing Market by Application
- 11.2.5 Canada Large And Small-scale Bioprocessing Market by Workflow
- 11.2.6 Canada Large And Small-scale Bioprocessing Market by Product
- 11.3 Mexico Large And Small-scale Bioprocessing Market
- 11.3.1 Mexico Large And Small-scale Bioprocessing Market by Scale
- 11.3.2 Mexico Large And Small-scale Bioprocessing Market by Use Type
- 11.3.3 Mexico Large And Small-scale Bioprocessing Market by Mode
- 11.3.4 Mexico Large And Small-scale Bioprocessing Market by Application
- 11.3.5 Mexico Large And Small-scale Bioprocessing Market by Workflow
- 11.3.6 Mexico Large And Small-scale Bioprocessing Market by Product
- 11.4 Rest of North America Large And Small-scale Bioprocessing Market
- 11.4.1 Rest of North America Large And Small-scale Bioprocessing Market by Scale
- 11.4.2 Rest of North America Large And Small-scale Bioprocessing Market by Use Type
- 11.4.3 Rest of North America Large And Small-scale Bioprocessing Market by Mode
- 11.4.4 Rest of North America Large And Small-scale Bioprocessing Market by Application
- 11.4.5 Rest of North America Large And Small-scale Bioprocessing Market by Workflow
- 11.4.6 Rest of North America Large And Small-scale Bioprocessing Market by Product
- Chapter 12. Company Profiles
- 12.1 Merck KGaA
- 12.1.1 Company Overview
- 12.1.2 Financial Analysis
- 12.1.3 Segmental and Regional Analysis
- 12.1.4 Research & Development Expense
- 12.1.5 Recent strategies and developments:
- 12.1.5.1 Partnerships, Collaborations, and Agreements:
- 12.1.5.2 Acquisition and Mergers:
- 12.1.6 SWOT Analysis
- 12.2 Thermo Fisher Scientific, Inc.
- 12.2.1 Company Overview
- 12.2.2 Financial Analysis
- 12.2.3 Segmental and Regional Analysis
- 12.2.4 Research & Development Expenses
- 12.2.5 Recent strategies and developments:
- 12.2.5.1 Product Launches and Product Expansions:
- 12.2.5.2 Acquisition and Mergers:
- 12.2.5.3 Geographical Expansions:
- 12.2.6 SWOT Analysis
- 12.3 GE HealthCare Technologies, Inc.
- 12.3.1 Company Overview
- 12.3.2 Financial Analysis
- 12.3.3 Segmental and Regional Analysis
- 12.3.4 Research & Development Expenses
- 12.3.5 SWOT Analysis
- 12.4 Corning Incorporated
- 12.4.1 Company Overview
- 12.4.2 Financial Analysis
- 12.4.3 Segmental and Regional Analysis
- 12.4.4 Research & Development Expenses
- 12.4.5 SWOT Analysis
- 12.5 Sartorius AG
- 12.5.1 Company Overview
- 12.5.2 Financial Analysis
- 12.5.3 Segmental and Regional Analysis
- 12.5.4 Research & Development Expenses
- 12.5.5 Recent strategies and developments:
- 12.5.5.1 Partnerships, Collaborations, and Agreements:
- 12.5.5.2 Product Launches and Product Expansions:
- 12.5.5.3 Geographical Expansions:
- 12.5.6 SWOT Analysis
- 12.6 Lonza Group Ltd. (Capsugel)
- 12.6.1 Company Overview
- 12.6.2 Financial Analysis
- 12.6.3 Segmental and Regional Analysis
- 12.6.4 Research & Development Expenses
- 12.6.5 Recent strategies and developments:
- 12.6.5.1 Geographical Expansions:
- 12.6.6 SWOT Analysis
- 12.7 Meissner Filtration Products, Inc.
- 12.7.1 Company Overview
- 12.7.2 SWOT Analysis
- 12.8 Boehringer Ingelheim International Gmbh
- 12.8.1 Company Overview
- 12.8.2 Financial Analysis
- 12.8.3 Regional & Segmental Analysis
- 12.8.4 Research & Development Expenses
- 12.8.5 Recent strategies and developments:
- 12.8.5.1 Partnerships, Collaborations, and Agreements:
- 12.8.5.2 Geographical Expansions:
- 12.8.6 SWOT Analysis
- 12.9 F. Hoffmann-La Roche Ltd.
- 12.9.1 Company Overview
- 12.9.2 Financial Analysis
- 12.9.3 Segmental and Regional Analysis
- 12.9.4 Research & Development Expense
- 12.9.5 Recent strategies and developments:
- 12.9.5.1 Partnerships, Collaborations, and Agreements:
- 12.9.6 SWOT Analysis
- 12.10. Eppendorf SE
- 12.10.1 Company Overview
- 12.10.2 Financial Analysis
- 12.10.3 Segmental and Regional Analysis
- 12.10.4 Research & Development Expenses
- 12.10.5 Recent strategies and developments:
- 12.10.5.1 Geographical Expansions:
- 12.10.6 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
